EC5026

pM oral sEH epoxide hydrolase inhibitor

completed Ph. I HV study + in animal health

epoxide-opening transition-state mimic

J. Med. Chem., Feb. 7, 2021

EicOsis Human Health Inc., Davis, CA

8. The EicOsis oral soluble epoxide hydrolase (sEH) inhibitor, EC5026, is a compound currently intended as a non-opioid analgesic and anti-inflammatory agent. It recently completed a Ph. I study…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.